Form 4: Myriad Genetics Executive Reports Stock Grant

Myriad Genetics Chief Technology Officer, Jampa Raj, received a grant of 251,889 restricted stock units.

Summary

• Jampa Raj, Chief Technology Officer at Myriad Genetics Inc., was granted 251,889 restricted stock units (RSUs) on June 1, 2026.
• These RSUs are part of the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan.
• The RSUs vest in four equal annual installments, starting on the first anniversary of the grant date.
• The reported transaction code is 'A' for acquisition, with a price of $0, indicating a grant rather than a purchase.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard executive compensation practice rather than a significant financial event or strategic shift.

Positives

• Grant of restricted stock units to a key executive, indicating a commitment to retaining talent and aligning executive interests with shareholder value.
• The grant is structured with a vesting schedule, encouraging long-term commitment from the Chief Technology Officer.

Negatives

• The filing does not contain any negative financial or operational information.

Risks

• Vesting of RSUs is contingent on continued employment, meaning a departure before vesting would result in forfeiture of the unvested portion.
• The value of the RSUs is tied to the performance of Myriad Genetics' common stock, which is subject to market volatility and company-specific risks.

Future Outlook

The vesting schedule of the restricted stock units implies a future outlook where the executive's continued service is expected to lead to the realization of these equity awards.

Industry Context

StockSavvy.ai notes that grants of restricted stock units are a common form of executive compensation in the biotechnology and genetics industries, used to attract, retain, and incentivize key personnel by aligning their financial interests with the long-term performance of the company.

Stakeholder Impact

• Shareholders: The grant aligns executive incentives with long-term company performance, potentially benefiting shareholders if the stock price increases.
• Employees: The grant highlights the company's use of equity-based compensation, which may influence employee morale and retention strategies.
• Management: The Chief Technology Officer receives a significant equity award, reinforcing their role and commitment to the company.

Next Steps

• Vesting of restricted stock units in four equal annual installments, beginning on the first anniversary of the grant date.

Key Dates

Keywords

Myriad Genetics, MYGN, Form 4, Stock Grant, Restricted Stock Units, RSU, Executive Compensation, Equity Incentive Plan, Jampa Raj, Chief Technology Officer